VistaPharm KERR INSTA-CHAR Recall Issued

Source: FDA · United States

Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.

PAI Holdings LLC is recalling one lot of VistaPharm KERR INSTA-CHAR due to failure to meet OTC Monograph requirements.

What this FDA recall tells you, and what most readers miss

This notice was issued by FDA on August 1, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.

Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.

Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drugs.

What Happened

PAI Holdings LLC initiated a voluntary recall of a drug product after it was determined that the product did not meet the Over-the-Counter (OTC) Monograph M023.

Which Products Are Affected

The affected product is VistaPharm, KERR INSTA-CHAR IN AN SORBITOL BASE WITH CHERRY FLAVOR, 25 Grams Activated Charcoal in 26 Grams Sorbitol in 120 mL (4 fl oz), distributed by VistaPharm, Inc., Largo, FL 33771, NDC 66689-203-04. The recall covers Lot #: AE006, expires: 5/31/2026. Distribution was nationwide in the United States.

What You Should Do

Consumers should check the lot number on any KERR INSTA-CHAR product in their possession and contact the recalling firm for further instructions.

Why This Matters

The recall addresses a quality issue with an activated charcoal product distributed across the United States.

Source

FDA recall D-0591-2026. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Original source: FDA Official Notice ↗

All FDA Recalls →

Nationwide notices with similar length or severity timing 8

Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.

Frequently Asked Questions

Common questions about this FDA recall.

What is this FDA recall about?
PAI Holdings LLC is recalling one lot of VistaPharm KERR INSTA-CHAR due to failure to meet OTC Monograph requirements.
Which agency issued this alert?
This alert was issued by FDA. The original notice is available at the source link at the bottom of this article.
How severe is this alert?
This alert is classified as "medium" severity. Stay informed and follow agency guidance.
What area is affected?
This alert affects United States. Check with FDA for the most current geographic scope.
Where can I find more FDA Recalls updates?
Browse the full FDA Recalls feed on Areazine at areazine.com/recalls/fda/ for the latest updates from FDA and other agencies.